Introduces Comprehensive Solution for the Xoft System for Busy Clinical Practices

NASHUA, N.H. and SAN FRANCISCO, C.A. (Booth # 5151) – iCAD, Inc. (Nasdaq: ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, today announced that researchers will present three E-posters highlighting results of up to four years of follow up with the Xoft Axxent® Electronic Brachytherapy (eBx®) System® in the treatment of non-melanoma skin cancer (NMSC) at The American Academy of Dermatology 73rd Annual Meeting in San Francisco, California. The Xoft System’s suite of products and services for clinical practices will also be showcased at the Xoft booth (#5151) throughout the meeting from March 20-24.

“This clinical data includes positive safety, efficacy and cosmetic results from patients treated in the longest-running NMSC clinical trial of the Xoft System to date,” said Ken Ferry, CEO of iCAD. “Collectively, 848 patients are being followed in the three studies evaluating the Xoft System’s effectiveness for the treatment of non-melanoma skin cancer. As more long-term data from these studies become available, we believe it will drive increased adoption by physicians and greater interest from patients in this unique non-surgical treatment option. We are also pleased to showcase our new comprehensive solution at the AAD meeting, which is lowering the technological and logistical barriers for customers, helping more physicians adopt the Xoft System in their practices.”
The E-posters will be presented at the meeting in the Non-Melanoma Skin Cancer section at E-Poster Presentation Center 1 and will be available to view online at www.aad.org on Friday, March 20, 2015.

- Electronic Brachytherapy for Non-Melanomatous Skin Cancer: Report of First 565 Lesions
E-Poster #2027
Stephen Doggett, M.D., Aegis Oncology, LLC
Monday, March 23, 2015 from 11:50 a.m. to 11:55 a.m.

- Electronic Brachytherapy for the Treatment of Non-Melanoma Skin Cancer: Results up to 4 Years
E-Poster #2005
Ajay Bhatnagar, M.D., MBA, 21st Century Oncology of Arizona
Monday, March 23, 2015 from 11:55 a.m. to 12:00 p.m.

- Initial Experience of Electronic Brachytherapy for the Treatment of 508 Non-melanoma Skin Cancer (NMSC) Lesions in 305 Patients
E-Poster # 2013
Robert Strimling, M.D., FAAD and Camtu Lee Jones
Monday, March 23, 2015 from 12:35 p.m. to 12:40 p.m.

“Study results suggest that electronic brachytherapy is an effective treatment for patients with non-melanoma skin cancer, with few recurrences or side effects and excellent cosmetic results,” said Ajay Bhatnagar, MD, MBA, medical director of 21st Century Oncology of Arizona. “The studies support the use of the Xoft System for patients with non-melanoma skin cancer who are not candidates for surgical excision or traditional radiation therapy.”

More HCB News